Advanced Medical Solutions Group Share News (AMS)
AMS Share
AMS Share
AMS Share
AMS Share
AMS
AMS Share
AMS Level 2
AMS Live
AMS Broker
AMS Directors
AMS Financial
AMS
AMS Short
AMS
Last checked at -
Mon, 16th Sep 2013 16:28
Advanced Medical Solutions: Investec reduces target price from 93p to 68p and downgrades from buy to hold. Numis downgrades to hold, while maintaining the target price at 165p. Canaccord Genuity moves target price from 93p to 90p and retains a buy recommendation. Anglo American: JP Morgan moves tar
Read moreIn the Financial Times, the Lex column urges caution on the apparent temptation of Nokia. The stock has collapsed 92pc in the last five years, hammered by the emergence of Apple's iPhone. In the last month though the stock has recovered somewhat, buoyed by Apple's victory in a US patent case against
Read moreWounds treatment firm Advanced Medical Solutions was in demand after it posted a jump in profits and raised its dividend. Profit before tax was up 72% to £4.5m on revenues that were up 52% to £24.8m in the first half of the year. The firm pushed up its interim dividend to 0.17p per share, an incre
Read more888 Holdings: Investec upgrades from sell to buy target hiked from 18p to 95p. Advanced Medical Solutions: Singer Capital Markets upgrades to buy, target lifted from 80p to 82p. AstraZeneca: AlphaValue downgrades to reduce. Bunzl: Jefferies raises target from 835p to 860p, underperform rating kep
Read moreAdvanced Medical Solutions: Peel Hunt upgrades to buy. Cairn Energy: UBS cuts target from 365p to 275p, neutral rating kept. Carnival: Jefferies maintains buy recommendation and 2,400p target. Carpetright: Peel Hunt keeps hold rating and 600p target. Cookson: Exane BNP Paribas cuts target from 7
Read moreAdvanced Medical Solutions, the wound care specialist, has warned currency movements and the end of a rolling order are likely to hit full year revenues. AMS bought a German firm, RESORBA, in 2011, the effect being that more revenues are denominated in euros. The euro's current weakness means the c
Read moreAdvanced Medical Solutions: Investec upgrades from hold to buy, target lift at 97p. Antofagasta: UBS downgrades from neutral to sell, target cut from 1,150p to 1,050p. Aquarius Platinum: UBS cuts target from 160p to 155p, neutral rating unchanged. BHP Billiton: UBS cuts target from 2,600p to 2,50
Read moreWound care product manufacturer Advanced Medical Solutions has reported a rise in sales during the twelves months ended December 31st, but the figures seemed to have failed to live up to market expectations. Profit before tax grew from £4.3m in 2010 to £4.6m in 2011, on revenues of £34.35m (2010:
Read moreAmec: Citi upgrades to buy from sell. Royal Dutch Shell: Citi downgrades to neutral from buy. Petrofac: Investec reiterates buy, 1,705p target under review. Petrofac: Evolution Securities reiterates add and 1,700p target. Whitbread: Evolution Securities keeps buy rating and 1,800p target. Whitb
Read moreWound care specialist Advanced Medical Solutions (AMS) is proposing to acquire RESORBA, a wound care business, for €63.8m (£55m). To fund the acquisition the firm is placing over 42m shares in AMS at a price of 73p per share to raise £34m. The acquisition is expected to be earnings per share enh
Read moreStocks remain buoyant amid hopes that the Eurozone situation may be nearing some kind of resolution. Office provider Regus in particular is benefiting from increased risk appetite. The shares are up more than 17%. Company updates are also attracting attention. Shares in Dixons gave up strong gain
Read moreShares are buoyant in early dealings, with some well-received updates from the retail sector lightening the mood. Consumer electronics retailer Dixons said like-for-like sales were down 7% from a year earlier in the 12 weeks to 23 July. The PC World and Currys owner said total group sales were down
Read moreWound care specialist Advanced Medical Solutions revealed an 80% increase in half year profit after strong sales of its ActivHeal range. For the six months ended 30 June 2011 profit from operations, post exceptional items, rose to £2.62m from £1.5m the year before. Profit from operations, pre-excep
Read moreResults from Advanced Medical Solutions (AMS) were so well received by the market on Tuesday that the company was trying to manage down expectations for its LiquiBand wound closure product, which enjoyed a better than expected launch in the USA. Group revenue in 2010 rose 32% to £31.9m from £24.1m
Read moreTechnology hardware and equipment is the worst performing sector, helped lower by Pace and BATM Advanced Communications, who both disappointed investors with 2010 results this week. Shares in telecoms equipment supplier BATM have continued to fall since Monday after it said that pre-tax profits sli
Read more
Last checked at